These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 27044149)

  • 1. Importance of foot and mouth disease vaccine purity in interpreting serological surveys.
    Smitsaart E; Espinoza AM; Maradei E; Cosentino B; Guinzburg M; Madonni G; Cadenazzi G; Bottini R; Filippi J; Bergmann I
    Rev Sci Tech; 2015 Dec; 34(3):755-66, 741-54. PubMed ID: 27044149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of foot-and-mouth disease (FMD) vaccination on virus transmission and the significance for the field.
    Orsel K; Bouma A
    Can Vet J; 2009 Oct; 50(10):1059-63. PubMed ID: 20046605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cedivac-FMD can be used according to a marker vaccine principle.
    Chénard G; Selman P; Dekker A
    Vet Microbiol; 2008 Apr; 128(1-2):65-71. PubMed ID: 18035508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production and application of recombinant antibodies to foot-and-mouth disease virus non-structural protein 3ABC.
    Foord AJ; Muller JD; Yu M; Wang LF; Heine HG
    J Immunol Methods; 2007 Apr; 321(1-2):142-51. PubMed ID: 17328909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Updating of the correlation between lpELISA titers and protection from virus challenge for the assessment of the potency of polyvalent aphtovirus vaccines in Argentina.
    Maradei E; La Torre J; Robiolo B; Esteves J; Seki C; Pedemonte A; Iglesias M; D'Aloia R; Mattion N
    Vaccine; 2008 Dec; 26(51):6577-86. PubMed ID: 18835312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of the immune response to FMDV structural and non-structural proteins in cattle in Argentina by the combined use of liquid phase and 3ABC-ELISA tests.
    Robiolo B; Seki C; Fondevilla N; Grigera P; Scodeller E; Periolo O; La Torre J; Mattion N
    Vaccine; 2006 Feb; 24(7):997-1008. PubMed ID: 16171905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effectiveness of vaccination to prevent foot and mouth disease in several species].
    Orsel K
    Tijdschr Diergeneeskd; 2008 Jan; 133(1):14-6. PubMed ID: 18260556
    [No Abstract]   [Full Text] [Related]  

  • 8. The field effectiveness of routine and emergency vaccination with an inactivated vaccine against foot and mouth disease.
    Elnekave E; Li Y; Zamir L; Even-Tov B; Hamblin P; Gelman B; Hammond J; Klement E
    Vaccine; 2013 Jan; 31(6):879-85. PubMed ID: 23246551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ring vaccination against foot-and-mouth disease.
    Tom B; Moutou F; Dufour B; Durand B
    Comp Immunol Microbiol Infect Dis; 2002 Oct; 25(5-6):365-72. PubMed ID: 12365811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomised field trial to evaluate serological response after foot-and-mouth disease vaccination in Turkey.
    Knight-Jones TJ; Bulut AN; Gubbins S; Stärk KD; Pfeiffer DU; Sumption KJ; Paton DJ
    Vaccine; 2015 Feb; 33(6):805-11. PubMed ID: 25528523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Control and eradication of foot-and-mouth disease.
    Sutmoller P; Barteling SS; Olascoaga RC; Sumption KJ
    Virus Res; 2003 Jan; 91(1):101-44. PubMed ID: 12527440
    [No Abstract]   [Full Text] [Related]  

  • 12. A Review of OIE Country Status Recovery Using Vaccinate-to-Live Versus Vaccinate-to-Die Foot-and-Mouth Disease Response Policies I: Benefits of Higher Potency Vaccines and Associated NSP DIVA Test Systems in Post-Outbreak Surveillance.
    Barnett PV; Geale DW; Clarke G; Davis J; Kasari TR
    Transbound Emerg Dis; 2015 Aug; 62(4):367-87. PubMed ID: 24112127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serological responses of cattle inoculated with inactivated trivalent foot-and-mouth disease vaccine at the wildlife-livestock interface of the Kruger National Park, South Africa.
    Lazarus DD; van Schalkwyk OL; Burroughs REJ; Mpehle A; Reininghaus B; Rikhotso O; Heath L; Maree FF; Blignaut B; Fosgate GT
    Prev Vet Med; 2018 Oct; 158():89-96. PubMed ID: 30220400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reintroduction of foot-and-mouth disease in Argentina: characterisation of the isolates and development of tools for the control and eradication of the disease.
    Mattion N; König G; Seki C; Smitsaart E; Maradei E; Robiolo B; Duffy S; León E; Piccone M; Sadir A; Bottini R; Cosentino B; Falczuk A; Maresca R; Periolo O; Bellinzoni R; Espinoza A; Torre JL; Palma EL
    Vaccine; 2004 Oct; 22(31-32):4149-62. PubMed ID: 15474705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modeling the impact of vaccination control strategies on a foot and mouth disease outbreak in the Central United States.
    McReynolds SW; Sanderson MW; Reeves A; Hill AE
    Prev Vet Med; 2014 Dec; 117(3-4):487-504. PubMed ID: 25457133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccination against foot-and-mouth disease I: epidemiological consequences.
    Backer JA; Hagenaars TJ; Nodelijk G; van Roermund HJ
    Prev Vet Med; 2012 Nov; 107(1-2):27-40. PubMed ID: 22749763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiating infection from vaccination in foot-and-mouth-disease: evaluation of an ELISA based on recombinant 3ABC.
    Bruderer U; Swam H; Haas B; Visser N; Brocchi E; Grazioli S; Esterhuysen JJ; Vosloo W; Forsyth M; Aggarwal N; Cox S; Armstrong R; Anderson J
    Vet Microbiol; 2004 Jul; 101(3):187-97. PubMed ID: 15223123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune responses of pigs to commercialized emulsion FMD vaccines and live virus challenge.
    Chen SP; Lee MC; Sun YF; Cheng IC; Yang PC; Lin YL; Jong MH; Robertson ID; Edwards JR; Ellis TM
    Vaccine; 2007 May; 25(22):4464-9. PubMed ID: 17445957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The NSP immune response of vaccinated animals after in-field exposure to FMDV.
    Yadin H; Brenner J; Chai D; Oved Z; Hadany Y; Kusak A; Haimovich M
    Vaccine; 2007 Nov; 25(49):8298-305. PubMed ID: 17981376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Residual foot-and-mouth disease virus antibodies in French cattle and sheep six years after the vaccination ban.
    Remond M; Kaiser C; Lebreton FO; Moutou F; Crucière C
    Vet Res; 2001; 32(1):81-6. PubMed ID: 11254180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.